We analyzed the prognosis of 30 patients with cholangiocarcinoma using GSE107943 from the GEO database and the results showed that higher expression of XPO1 was significantly associated with poor patient prognosis in CHOL (Figure 2G). Here, XPO1 is linked to cholangiocarcinoma.